MiMedx Planning U.S. Launch for Ambient Temperature Version of OrthoFlo
MiMedx is planning a U.S. launch for a next-generation lyophilized version of OrthoFlo, its amniotic fluid-based allograft for use in in orthopaedic and sports-medicine applications.  Jul 25, 2016